News|Articles|October 14, 2024
Marken’s Rapid Response to Crowdstrike Crisis Ensures Vital Therapy Distribution to Patients
Author(s)Marken
Related Content
Sponsored Content
- News
- Publications
- Multimedia
- Conferences
- Webcasts
- Resources
- Event Calendar
- Subscribe
- Analytics
- Data and Artificial Intelligence
- Dosage Forms
- Drug Development
- Manufacturing
- Aseptic/Sterile Processing
- Equipment
- Process and Automation
- Manufacturing, Parenterals and Injectables
- Manufacturing, Biosimilars and Biobetters
- Manufacturing, Inhalation Drugs
- Manufacturing, Solid and Semi-Solid Dosage Drugs
- Manufacturing, Cell Therapies
- Manufacturing, Biologic Drugs
- Supply Chain
- Manufacturing, Gene Therapies
- Packaging and Distribution
- Outsourcing
- Quality Systems